Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
03/2004
03/10/2004EP1395557A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/10/2004EP1395556A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/10/2004EP1395555A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/10/2004EP1136477B1 Benzofuran derivatives, process for the preparation of the same and uses thereof
03/10/2004CN1141093C Anticancer lichee lectone medicine and its prepn
03/04/2004US20040044051 Cannabinoid receptor agonists
03/04/2004US20040044015 Quinazoline derivatives
03/03/2004EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME
03/03/2004EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators
03/03/2004EP1087780B1 Extraction method of a compound from vegetable material
03/03/2004EP0841916B9 Endothelin receptor antagonists
03/03/2004CN1479728A Pexoxisome proliferator activated receptor alpha agonists
03/02/2004US6700013 O-bromophenylacetic acid derivative chemical intermediate; smooth muscle relaxants, antiinflammatory agents; respiratory system disorders
03/02/2004US6699860 Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
02/2004
02/26/2004WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof
02/26/2004US20040039049 Stable amorphous calcium pseudomonate and processes for the preparation thereof
02/26/2004US20040039016 HIV protease inhibitors
02/26/2004US20040038977 Treating arthritis, pain and cancer
02/26/2004US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc.
02/26/2004US20040038957 Anti-malarial activity
02/25/2004EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials
02/25/2004EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
02/25/2004EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
02/25/2004EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors
02/24/2004US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments
02/24/2004CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
02/19/2004WO2004014919A1 Epothilone derivatives
02/19/2004WO2004014886A1 Antigiardial agents and use thereof
02/19/2004WO2004014871A1 Vanilloid receptor ligands and their use in treatments
02/19/2004WO2004014372A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
02/19/2004WO2003065975A3 Processes for preparing crystalline and amorphous mupirocin calcium
02/19/2004US20040034239 Inhibitors of nadh:ubiquinone oxidoreductase
02/19/2004US20040034230 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent
02/19/2004US20040034049 A benzofuran derivatives for treating neurodegenerative disease, such as Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis and Huntington's disease
02/19/2004US20040034047 E.g. 5-(6,7-dimethoxy-2-(4-methoxybenzyl)benzofuran-4-yl-methyl-)pyrimidine-2,4 -diamine; bactericides for infections of grampositive and gramnegative pathogens; more potent than Trimethoprim, especially against respiratory tract pathogens
02/19/2004US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings
02/19/2004CA2494259A1 Epothilone derivatives
02/18/2004EP1389202A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
02/18/2004CN1476436A Novel compounds for use as HIV protease inhibitors
02/17/2004US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases
02/17/2004US6692657 Alkenyl compound with 2,3-difluorophenyl group
02/12/2004WO2004013153A2 Macrolide compounds endowed with antiinflammatory activity
02/12/2004WO2004013120A1 Novel benzodioxoles
02/12/2004WO2004013093A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use
02/12/2004WO2004012656A2 Thiophene and furan derivatives as prostaglandin agonists and use thereof
02/12/2004WO2003049702A3 Vanilloid receptor ligands and their use in treatments
02/12/2004US20040029874 Anticoagulants; cardiovascular disorders
02/12/2004CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use
02/11/2004EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
02/11/2004EP1387679A1 Sulfonamides
02/11/2004CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
02/10/2004US6689891 2-bromomethyl-6-methyl-benzoic acid and a process for the preparation thereof
02/10/2004US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same
02/10/2004US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/05/2004WO2004011661A1 Novel physiologically active substances
02/05/2004WO2004011459A1 Novel physiologically active substance
02/05/2004WO2004011458A1 Total synthesis of myriaporones
02/05/2004US20040024190 Viral polymerase inhibitors
02/05/2004US20040024052 Processes for preparing crystalline and amorphous mupirocin calcium
02/05/2004US20040024051 C10 heterosubstituted acetate taxanes
02/05/2004US20040024049 Cytotoxic agents containing novel potent taxanes and their therapeutic use
02/05/2004US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases
02/05/2004US20040023958 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.
02/05/2004US20040023945 Cyclic amp-specific phosphodiesterase inhibitors
02/05/2004CA2494532A1 Total synthesis of myriaporones
02/04/2004EP1385838A1 Piperazino-derivatives and their use as pde4 inhibitor
02/04/2004EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/04/2004EP1042319B1 Dihydrobenzofurans
02/04/2004CN1473161A Pyrazole compounds as protein kinase inhibitors
02/03/2004US6686483 Reacting an oxidizer with an olefin in presence of ketone
02/03/2004US6685995 Low voltage, wide temperature range driving; high speed response
01/2004
01/29/2004WO2004009544A1 2-cyano-4-fluoropyrrolidine derivative or its salt
01/29/2004US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
01/29/2004CA2493339A1 2-cyano-4-fluoropyrrolidine derivative or salt thereof
01/28/2004EP1384721A1 Stable amorphous calcium pseudomonate and processes for the preparation thereof
01/28/2004EP1383757A1 Antagonists of mcp-1 function and methods of use thereof
01/28/2004EP1383756A1 Coumarin derivatives to be used as anticoagulants
01/28/2004CN1471521A Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same
01/28/2004CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
01/27/2004US6683196 Reacting racemic beta-lactam with lithium- 7-protected baccatin iii- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents
01/27/2004US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
01/27/2004CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them
01/25/2004CA2429287A1 Stable amorphous calcium pseudomonate and processes for the preparation thereof
01/22/2004WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
01/22/2004US20040014979 For use as antitumor agents
01/22/2004US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity
01/22/2004CA2492100A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
01/21/2004EP1381359A1 Aurones as telomerase inhibitors
01/21/2004EP1313749A4 Process for preparation of anhydrous azithromycin
01/21/2004CN1469875A Pyrazole compounds useful as protein kinase inhibitors
01/21/2004CN1469874A Pyrazole compounds useful as protein kinase inhibitors
01/20/2004CA2303498C Dioxocyclopentyl hydroxamic acids
01/15/2004WO2004005917A1 Fluorescent probe
01/15/2004WO2004005252A1 Azabicyclo derivatives as muscarinic receptor antagonists
01/15/2004WO2004004726A1 Mchir antagonists
01/15/2004WO2004004629A2 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
01/15/2004WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
01/15/2004US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors
01/15/2004US20040010011 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
01/15/2004CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 120